Management of Candida Diaper Rash and Thrush in Neonates

Home Care Instructions

The American Academy of Pediatrics recommends administering fluconazole once daily at the same time each day for the complete 6-day course, even if symptoms improve earlier, with a half-life in neonates of 55-90 hours, allowing for once-daily dosing 1
The Infectious Diseases Society of America suggests that do not stop treatment early when symptoms improve, as mycological cure is the goal, not just clinical improvement, with the combination of systemic fluconazole and topical therapy addressing both superficial and deeper candidal involvement 1, 2
If breastfeeding, the mother must simultaneously treat her nipples with miconazole cream after each feeding to prevent reinfection, and sterilize pacifiers, bottle nipples, and any objects that go in the infant's mouth daily by boiling for 20 minutes 1

The Centers for Disease Control and Prevention indicates that fever, lethargy, decreased responsiveness, or irritability may indicate progression to invasive candidiasis, and poor feeding or refusal to feed can signal systemic illness 3, 4, 5
The American Academy of Pediatrics recommends that worsening rash despite 3 days of fluconazole treatment suggests treatment failure or resistant organism, and persistent thrush after 7 days of treatment may require extended therapy or evaluation for immunodeficiency 1

The Infectious Diseases Society of America suggests that no improvement by day 3 or worsening at any point warrants reassessment, and at the 5-day follow-up, if not resolving, consider increasing fluconazole dose to 12 mg/kg/day or obtaining fungal cultures to identify species and assess for azole-resistant organisms 1, 2, 4, 5, 6
The American Academy of Pediatrics recommends that age <17 days places this infant in the highest-risk period for invasive candidiasis, and if the infant has additional risk factors, maintain higher suspicion for disseminated disease 3, 4

The Infectious Diseases Society of America suggests that amphotericin B deoxycholate 1 mg/kg/day IV is the traditional first-line for invasive disease in neonates, and micafungin 4-10 mg/kg/day IV is increasingly used, with higher doses if CNS involvement suspected 4, 5, 7
The American Academy of Pediatrics recommends that liposomal amphotericin B 2.5-7 mg/kg/day IV can be used for refractory cases or if conventional amphotericin toxicity is a concern 4, 7

The Centers for Disease Control and Prevention indicates that discontinuing treatment when clinical appearance improves but before mycological cure leads to high recurrence rates, and failing to treat the breastfeeding mother simultaneously results in ping-pong reinfection 1, 2
The Infectious Diseases Society of America suggests that not considering invasive candidiasis in a neonate with persistent mucocutaneous disease can lead to worse outcomes, and assuming all Candida species respond equally to fluconazole is incorrect, as C. krusei is intrinsically resistant and C. glabrata often has reduced susceptibility 5, 6